Brain and Stroke Researchers Meet at UC March 10-13
Some of the nations leading scientists and physicians specializing in stroke and neurological diseases will meet at three scientific events at the Kingsgate Marriott to share the latest research and treatment approaches.
According to the American Heart Association, someone in the United States has a stroke every 45 seconds. Tristate residents suffer about 3,500 strokes and TIAs (transient ischemic attacks) each year, or over 10 a day.
UC is hosting the March 1011 annual meeting of the six centers involved in the network for Specialized Programs of Translational Research in Acute Stroke (SPOTRIAS). UC was the first to join the network, which is funded by the National Institutes of Health.
Investigators from the nations premier stroke centers will discuss the latest results from ongoing clinical trials. These include studies of the ability of drug combinations to break up clots, the use of mechanical devices to remove clots, telemedicine to aid treatment in isolated hospitals, blood markers to help predict risk and outcome therapies, and brain imaging to monitor recovery.
On March 11 and 12, the Ninth Cincinnati Neurofest will discuss new therapies and improved patient care for epilepsy, drug abuse, neurodegenerative disorders such as Parkinsons disease, and the latest findings on brain imaging, gene research and treatments for brain disease.
The Third Cincinnati Translational Neuroscience Symposium will meet at the Kingsgate March 12, where the program will include presentations from UC faculty members Russell Buono, PhD, Michael Privitera, MD, Timothy Collier, PhD, of the neurology department, Tracy Glauser, MD, neurology and pediatrics, and Randy Hillard, MD, psychiatry.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.